T1	Outcomes 0 6	Safety
T2	Outcomes 11 37	preliminary immunogenicity
T3	Outcomes 491 501	the safety
T4	Outcomes 515 533	the immunogenicity
T5	Outcomes 655 669	well tolerated
T6	Outcomes 674 681	as safe
T7	Outcomes 824 867	significant increase of IgG GMC and OPA GMT
